Mr. Clayton Mathile served as Advisory Board Member at Myrian Capital. Clay joined The Iams Company in the 1970s and eventually became chief executive and chairman of the board. In 1974, Mathile bought half of the company from its founder for $100,000; seven years later, he bought the rest of the company. In 1999, the Mathile family sold Iams to global consumer goods manufacturer Procter & Gamble for $2.3 billion. Mathile is CEO of CYMI Technologies and has an exemplary entrepreneurial and executive track record as an active investor in the emerging tech industry. In 2003, Mathile became a major investor in Riverain Medical, an industry leader and technology innovator in early detection of life-threatening diseases. In 2007, Mathile took the lead investor position in ooVoo, a web-based video communications firm facing off against Internet calling company Skype. ooVoo, which has proven to be far superior to its rival, has 16 million users-currently adding 1 million each month. Mathile is also heavily invested in Ensequence, a leading interactive TV company. However, he devotes much of his time to philanthropic endeavors. He is chairman and chief executive officer of The Mathile Institute for the Advancement of Human Nutrition, a non-profit organization he founded that is focused on creating innovative, effective and sustainable solutions to alleviate world hunger and malnutrition in children. Mathile is also the founder of Aileron, an operating foundation that focuses on the development of privately held businesses by providing business owners with the tools and support they need to mature and succeed.